Navigation Links
Venugopal Should Not Have Gone Public: Ramadoss

Union Health Minister Anbumani Ramadoss came down heavily on AIIMS Director P Venugopal for accusing him of 'interfering' in the functioning of the premier institute // and threatening to resign, saying he should not have gone public on the issue.

Speaking to PTI, Ramadoss said, 'It is very wrong that he has gone public. If he had any problem, he could have discussed with me. I was and am always available.' Denying that he had interfered in the functioning of AIIMS, he said as president of the institute, he had certain obligations and duties to perform.

'Is performing duty interference?' he asked adding that the charges levelled against him by Venugopal were 'rubbish'.

Justifying the appointment of a dean for AIIMS, he said the post had remained vacant for a long time. 'How could a prestigious institute function without a dean for a long time?' he asked.

Ramadoss said the fund allocation for AIIMS had been hiked from Rs 350 crore to Rs 500 crore during his tenure. He has also made the trauma care centre at the institute functional, besides completing the construction of a building for cancer care.

'If all this is interference, I am glad to interfere,' he said.

Ramadoss said when he had become the Health Minister, the lack of administration in AIIMS was visible. He had taken steps to tone up the administration. The charges against him were a 'continuation' of the anti-quota stir of last month, he said.

(Source:PTI News)
'"/>




Page: 1

Related medicine news :

1. AIIMS Doctors Seeks Ramadoss Intervention For Venugopal’s Remova
2. AIIMS Director Venugopal Sacked
3. Venugopal will not be Sacked Before Court Verdict: Central Government
4. Delhi High Court Stays Venugopals Removal
5. Normalcy Returns To AIIMS; Venugopal Attends Office
6. AIIMS Official Files Complaint Against Venugopal
7. AIIMS Director Venugopal Removed from Additional Post
8. Court Issues Notice to Venugopal Over Fund Irregularities
9. Babies Should Get Vitamin D Supplement
10. How Much Should Athletes Drink?
11. Angioplasty Should be the Standard
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... Patients who would like ... in a fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria ... now offers this revolutionary treatment with or without a referral. , Wilckodontics ...
(Date:4/25/2017)... ... , ... Back Pain Centers of America (BPC), which connects people ... their area, announces the launch of a new and proprietary customer relationship management (CRM) ... reputable physicians to help them with back or neck pain and helps to match ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a ... its patient care management module. Using this new feature, sleep physicians can now ... initiated on continuous positive airway pressure (CPAP), oral, or other forms of sleep ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® , a ... UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event ... the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair ...
(Date:4/24/2017)... FLORIDA (PRWEB) , ... April 24, 2017 , ... ... telehealth technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, ... LG CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed tablet ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... 18, 2017 Cogentix Medical, Inc. (NASDAQ: CGNT), ... Urology, Uro/Gyn and Gynecology markets with innovative and proprietary ... ended March 31, 2017 after the market close on ... will host a conference call and webcast to discuss ... 2, 2017 at 4:30 p.m. Eastern Time (3:30 p.m. ...
(Date:4/18/2017)... , April 18, 2017 Research and ... Market 2017-2021" report to their offering. ... The global arthroscopy devices market to grow at a ... report, Global Arthroscopy Devices Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
(Date:4/18/2017)... and BLOOMINGTON, Minn. , April ... IMMY ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, ... Lens"), today announced the signing of a three-year ... Lens will deploy a dedicated sales team to ... the U.S., primarily focused in 13 states in ...
Breaking Medicine Technology: